SAN FRANCISCO, CA--(Marketwired - Sep 26, 2013) - Sports analogies are used way too often in business, but MusclePharm Corp.'s (OTCQB: MSLP) Founder, President and CEO Brad Pyatt has used his experience as a wide receiver in the National Football League to build a nutritional supplement business, employing leadership tools he learned from great coaches and players. In this interview with George Mack from The Life Sciences Report, Pyatt talks about his young company's explosive growth, and how he expects to continue expanding both revenue and earnings to generate tremendous shareholder value.

The Life Sciences Report: You're a young CEO, now 33 years old. You founded MusclePharm Corp. after playing wide receiver in the National Football League (NFL). I'm wondering about your personal experience. Did you find nutritional supplements to be a big help to you as a college and pro football player? Do they really make a difference when added to standard training?

Brad Pyatt: I would say yes. Supplements support athletes who are at a high level and non-athletes just looking to increase their fitness. And though I wish there were such a thing, supplements are not miracle pills and powders.

If you have a good regimen of nutrition and training, supplements become the third plank of the program. Athletes and others will see a huge difference in performance, particularly with...

Continue reading this interview with Brad Pyatt: Muscling into the Nutritional Supplements Market: Brad Pyatt

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

DISCLOSURE:

MusclePharm Corp. paid The Life Sciences Report to conduct, produce and distribute the interview. MusclePharm Corp. had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of MusclePharm Corp. and not Streetwise Reports or The Life Sciences Report or its officers.